Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Nr0b2

  • Yuxia Zhang
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101707

Synonyms

Historical Background

The nuclear receptor small heterodimer partner (SHP, Nr0b2) was originally identified in 1996 as a transcriptional repressor based on its protein-protein interactions with several nuclear receptor superfamily members such as retinoid receptors, the thyroid hormone receptor, and the orphan receptor MB67 (Seol et al. 1996). The SHP gene consists of two exons and one intron located at human chromosome 1p36.11, mouse chromosome 4 D2.3, and rat chromosome 5q36. Since no endogenous ligand for SHP has been identified so for, SHP is classified as an orphan nuclear receptor. However, SHP is present in a variety of tissues. In mice, SHP is abundant in the gallbladder and liver while expressed at lower levels in the brainstem, cerebellum, adrenal, pancreas, stomach, duodenum, jejunum, ileum, colon, kidney, ovary, testis, and heart. In humans, SHP expression is detectable in the...

This is a preview of subscription content, log in to check access.

References

  1. Boulias K, Katrakili N, Bamberg K, Underhill P, Greenfield A, Talianidis I. Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP. EMBO J. 2005;24:2624–33.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell. 2000;6:517–26.CrossRefPubMedGoogle Scholar
  3. He N, Park K, Zhang Y, Huang J, Lu S, Wang L. Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth. Gastroenterology. 2008;134:793–802.CrossRefPubMedGoogle Scholar
  4. Huang J, Iqbal J, Saha PK, Liu J, Chan L, Hussain MM, et al. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology. 2007;46:147–57.CrossRefPubMedGoogle Scholar
  5. Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005;2:217–25.CrossRefPubMedGoogle Scholar
  6. Kim DH, Kwon S, Byun S, Xiao Z, Park S, Wu SY, et al. Critical role of RanBP2-mediated SUMOylation of small heterodimer partner in maintaining bile acid homeostasis. Nat Commun. 2016;7:12179.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Arterioscler Thromb Vasc Biol. 2007;27:2606–11.CrossRefPubMedGoogle Scholar
  8. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell. 2000;6:507–15.CrossRefPubMedGoogle Scholar
  9. Matsukuma KE, Wang L, Bennett MK, Osborne TF. A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor. J Biol Chem. 2007;282:20164–71.CrossRefPubMedGoogle Scholar
  10. Nishigori H, Tomura H, Tonooka N, Kanamori M, Yamada S, Sho K, et al. Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc Natl Acad Sci USA. 2001;98:575–80.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Pan X, Zhang Y, Wang L, Hussain MM. Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP. Cell Metab. 2010;12:174–86.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Park MJ, Kong HJ, Kim HY, Kim HH, Kim JH, Cheong JH. Transcriptional repression of the gluconeogenic gene PEPCK by the orphan nuclear receptor SHP through inhibitory interaction with C/EBPalpha. Biochem J. 2007;402:567–74.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science. 1996;272:1336–9.CrossRefPubMedGoogle Scholar
  14. Wang L, Lee YK, Bundman D, Han Y, Thevananther S, Kim CS, et al. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell. 2002;2:721–31.CrossRefPubMedGoogle Scholar
  15. Yang CS, Kim JJ, Kim TS, Lee PY, Kim SY, Lee HM, et al. Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome. Nat Commun. 2015;6:6115.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Yuk JM, Shin DM, Lee HM, Kim JJ, Kim SW, Jin HS, et al. The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors. Nat Immunol. 2011;12:742–51.CrossRefPubMedGoogle Scholar
  17. Zhang Y, Andrews GK, Wang L. Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP. Nucleic Acids Res. 2012;40:4850–60.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta. 2011;1812:893–908.CrossRefPubMedGoogle Scholar
  19. Zhang Y, Xu P, Park K, Choi Y, Moore DD, Wang L. Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology. 2008;48:289–98.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Zhi X, Zhou XE, He Y, Zechner C, Suino-Powell KM, Kliewer SA, et al. Structural insights into gene repression by the orphan nuclear receptor SHP. Proc Natl Acad Sci USA. 2014;111:839–44.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Pharmacology, Toxicology and TherapeuticsUniversity of Kansas Medical CenterKansas CityUSA